Effect of spinal orthosis on clinical outcomes of patients after oblique lumbar interbody fusion: a randomized controlled trial study protocol

被引:1
|
作者
Han, Nian-rong [1 ]
Osman, Akram [1 ]
Hu, Wei [1 ]
Huang, Yi-fei [1 ]
Liu, Yan-lu [1 ]
Ma, Zhan-jun [1 ]
机构
[1] Xinjiang Med Univ, 393 Xinyi Rd, Urumqi 830011, Xinjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Oblique lumbar interbody fusion; OLIF; Spinal orthosis; Lumbar minimally invasive surgery; Clinical efficacy; LOW-BACK-PAIN; MANAGEMENT;
D O I
10.1186/s13063-023-07796-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundOblique lumbar interbody fusion (OLIF) is an internationally popular minimally invasive technology for the treatment of various lumbar diseases. Since its introduction to China in 2014, OLIF technology has clearly shown its superiority in reconstructing intervertebral stability, restoring intervertebral space height, achieving indirect decompression, and restoring normal lumbar sequence. However, some patients still suffer from persistent symptoms after OLIF, including low back pain and soreness, which indirectly affect the overall surgical efficacy and patient satisfaction. Therefore, some clinicians recommend that patients routinely use spinal orthoses after OLIF to reduce the stress on the lower back muscles and ligaments, thereby relieving or avoiding postoperative residual symptoms or new symptoms. Accordingly, spinal orthosis use after OLIF has emerged as an essential option. However, the role of spinal orthoses in OLIF and their specific impact on postoperative patient clinical outcomes have remained unclear, and there is a lack of strong clinical evidence to indirectly or directly support the role of spinal orthoses in OLIF and demonstrate their impact on patient clinical outcomes. This study aims to investigate the role of spinal orthoses in OLIF by grouping patients based on the use or nonuse of spinal orthosis after OLIF, thus providing a better basis for the majority of patients and physicians.Methods/designWe plan to conduct a 1-year randomized controlled trial involving 60 subjects. The subjects will be randomized into two groups: group A (those wearing spinal orthoses after surgery) and group B (those not wearing spinal orthoses after surgery). The clinical outcomes of these patients will be evaluated using the Oswestry disability index, visual analog scale, and Brantigan, Steffee, Fraser 1 day before surgery and 2 weeks and 1, 6, and 12 months after surgery.DiscussionThis randomized controlled trial aims to provide a reference for further comprehensive trial design. The findings of this study will provide a better and more scientific basis for the choice of postoperative rehabilitation and treatment for patients undergoing such a procedure.Trial registrationThis study has been registered in the Chinese Clinical Trial Registry (Registration No.: ChiCTR2200059000). Registration date: April 22, 2022.Registration website: http://www.chictr.org.cn/showproj.aspx?proj=166310Trial registrationThis study has been registered in the Chinese Clinical Trial Registry (Registration No.: ChiCTR2200059000). Registration date: April 22, 2022.Registration website: http://www.chictr.org.cn/showproj.aspx?proj=166310
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Effect of spinal orthosis on clinical outcomes of patients after oblique lumbar interbody fusion: a randomized controlled trial study protocol
    Nian-rong Han
    Akram Osman
    Wei Hu
    Yi-fei Huang
    Yan-lu Liu
    Zhan-jun Ma
    Trials, 24
  • [2] Relationship Between Alterations of Spinal/Pelvic Sagittal Parameters and Clinical Outcomes After Oblique Lumbar Interbody Fusion
    Xiao, Liang
    Zhao, Quanlai
    Sun, Xiumin
    Liu, Chen
    Zhang, Yu
    Xu, Hongguang
    WORLD NEUROSURGERY, 2020, 133 : E156 - E164
  • [3] Clinical and Radiological Outcomes of Oblique Lateral Lumbar Interbody Fusion
    Abbasi, Ali
    Khaghany, Kamran
    Orandi, Vali
    Abbasi, Hamid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (02)
  • [4] A protocol of a randomized controlled multicenter trial for surgical treatment of lumbar spondylolisthesis: the Lumbar Interbody Fusion Trial (LIFT)
    Suzanne L. de Kunder
    Kim Rijkers
    Sander M. J. van Kuijk
    Silvia M. A. A. Evers
    Rob A. de Bie
    Henk van Santbrink
    BMC Musculoskeletal Disorders, 17
  • [5] A protocol of a randomized controlled multicenter trial for surgical treatment of lumbar spondylolisthesis: the Lumbar Interbody Fusion Trial (LIFT)
    de Kunder, Suzanne L.
    Rijkers, Kim
    van Kuijk, Sander M. J.
    Evers, Silvia M. A. A.
    de Bie, Rob A.
    van Santbrink, Henk
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17 : 1 - 7
  • [6] The Research on Spinopelvic Parameters and Clinical Outcomes of Oblique Lumbar Interbody Fusion and Transforaminal Lumbar Interbody Fusion in the Treatment of
    Yang, Pengchao
    Dong, Yimin
    Xu, Yong
    Kang, Honglei
    Li, Feng
    Guan, Hanfeng
    WORLD NEUROSURGERY, 2024, 190 : E841 - E850
  • [7] Enhanced Recovery After Surgery Protocol for Oblique Lumbar Interbody Fusion
    Shao, Xiaofeng
    Li, Renjie
    Zhang, Lichen
    Jiang, Weimin
    INDIAN JOURNAL OF ORTHOPAEDICS, 2022, 56 (06) : 1073 - 1082
  • [8] Enhanced Recovery After Surgery Protocol for Oblique Lumbar Interbody Fusion
    Xiaofeng Shao
    Renjie Li
    Lichen Zhang
    Weimin Jiang
    Indian Journal of Orthopaedics, 2022, 56 : 1073 - 1082
  • [9] Effects of “fixation-fusion” sequence of lumbar surgery on surgical outcomes for patients with lumbar spinal stenosis: study protocol for a multicenter randomized controlled trial
    Weicheng Pan
    Jialin Jiang
    Weihang Zhang
    Zijian Mei
    Kaiqiang Sun
    Bing Zheng
    Yake Meng
    Yushu Bai
    Zhimin He
    Jiangang Shi
    Yongfei Guo
    BMC Musculoskeletal Disorders, 24
  • [10] Effects of "fixation-fusion" sequence of lumbar surgery on surgical outcomes for patients with lumbar spinal stenosis: study protocol for a multicenter randomized controlled trial
    Pan, Weicheng
    Jiang, Jialin
    Zhang, Weihang
    Mei, Zijian
    Sun, Kaiqiang
    Zheng, Bing
    Meng, Yake
    Bai, Yushu
    He, Zhimin
    Shi, Jiangang
    Guo, Yongfei
    BMC MUSCULOSKELETAL DISORDERS, 2023, 24 (01)